আমাদের শান্তিনিকেতন কভিড সেল এখন লাইভ রয়েছেন৷
10 মিনিট ·
করোনার দ্বিতীয় আবহে পরিস্থিতি সংকটজনক। চেম্বারে ডাক্তার নেই, আবার যোগাযোগ ব্যবস্থা বিচ্ছিন্ন, অসহায় রোগীর পরিজনেরা, স্বাস্থ্য পরিষেবা উদ্বেগজনক।
এহেন পরিস্থিতির মোকাবিলায় শান্তিনিকেতন সেবা নিকেতন- এর ব্যবস্থাপনায় চলছে অনলাইন চিকিৎসা পরিষেবা/ টেলিমেডিসিন।
এই কর্মযজ্ঞ সম্পর্কে বিশদে জানতে প্রতিদিন সকাল ১০:৩০ টা থেকে ১১.৩০পযর্ন্ত, এবং রাত্রি ৯.৩০টা থেকে রাত্রি ১০.৩০টা পযর্ন্ত Google Meet -এর নিচের লিংকে ক্লিক করে অনলাইন মিটিং-এ অংশ নিতে সকলকে অনুরোধ জানাই। এটা আমাদের ফেসবুকে লাইভ চলবে সঙ্গে লাইক শেয়ার কমেন্ট করার জন্য অনুরোধ রইলো।

Meeting Link: http://meet.google.com/yxm-pchb-oyf

Watch Live  : https://fb.watch/6qpzLu26Hr/

An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched today, with Union Defence Minister Rajnath Singh distributing around 10,000 doses to some hospitals in the national capital.
The drug, called 2-deoxy-D-glucose or 2-DG, was developed by a DRDO lab in collaboration with the Hyderabad-based pharma giant, Dr Reddy’s Laboratories. Drugs Controller General of India (DCGI), the country’s top drug regulator, has approved the medicine for emergency use.

The medicine was found to be safe for COVID-19 patients in phase 2 trials, conducted between May and October last year. It was found to be effective in cutting short the hospital stays of Covid patients and reducing their supplemental oxygen dependence.

A kind of pseudo glucose molecule in the drug stops the virus in its tracks, the defence body says.

The medicine comes in powder form and can be taken with water.

2-DG is one of the few medicines across the world that have been designed specifically to treat COVID-19, which, as of now, has no cure. Doctors use several experimental drugs and procedures, including Remdevisir, Ivermectin, plasma therapy and some steroids, to treat the deadly infection.

Curtesy : NDTV NEWS

Compiled_CVC_plan-converted

Order_for_State_Committee_on_Oxygen (1)

4,31,285 beneficiaries of the age group 18-44 years received their first dose of COVID vaccine in the last 24 hours and cumulatively 34,80,618 across 30 States/UTs since the start of phase-3 of vaccination drive. Table below shows the cumulative vaccine doses administered to 18-44 years age group till now.
India’s cumulative recoveries stand at 1,97,34,823 today. The National Recovery Rate is 83.26%.
The National Mortality Rate currently stands at 1.09%.
For Details : https://pib.gov.in/PressReleasePage.aspx?PRID=1718217

The solution from Swadhin involves creating mass awareness through a combination Social Media and with our Health warriors The information shared is in strict compliance with Government protocols and available in the local languages. The contents focus on the following areas:
• Measures on social distancing
• Hand washing hygiene & procedure
• Understanding symptoms of COVID-19 and taking adequate measures
• Awareness building to seek doctor’s consultation
• Addressing phobia around quarantines and self isolation
• Address mental distress & anxiety
• Questionnaire for self assessment based on symptomatic behavior
• Questionnaire to assess awareness level
In order to drive the mass awareness and counseling, Swadhin has developed an initiative to train frontline health workers on a Train-The-Trainer approach. These Trainers will in turn train area volunteers/ representatives. These trained members will be deployed in the identified areas for awareness, counseling and identification of high risk members.

• The Doctor will be able to view patient details before, during and after the call. This includes demographics, vitals and clinical information such as prescriptions and results.
• The doctor can enter the prescription in the webinar and this can be viewed by the patient.

MINISTRY OF AYUSH
Note dated 26th April 2021

Guidelines for Ayurveda & Unani Practitioners for COVID-19 Patients in
Home Isolation and Ayurveda & Unani Preventive Measures for self care
during COVID-19 Pandemic released by Ministry of Ayush
Guidelines for Ayurveda & Unani Practitioners for COVID-19 Patients in Home
Isolation and Ayurveda & Unani Preventive Measures for self care during COVID19 Pandemic were released by Ministry of Ayush, Government of India on 26th
April 2021.
These guidelines for COVID-19 Patients in Home Isolation and Preventive
Measures for self care are based on based on leads from classical Ayurveda &
Unani texts, outcome of research studies, Report & Recommendations of the
Interdisciplinary Committee and which will further strengthen our fight in
combating COVID-19 in the emerging situation.
These Guidelines and Advisories were developed through extensive consultative
process by Empowered Committee within the Interdisciplinary Ayush Research
and Development Task Force setup by Ministry of Ayush. The Project
Monitoring Unit for COVID-19 Studies, Central Council for Research in
Ayurvedic Sciences (CCRAS), Central Council for Research in Unani Medicine
(CCRUM), All India Institute of Ayurveda (AIIA) and National Medicinal Plant
Board (NMPB) of this Ministry worked on formulating the advisories and
Guidelines.
The present Guidelines and self care measures provide clear guidance to Ayurveda
& Unani practitioners regarding treatment of COVID-19 patients in different
conditions of infection. This brings in uniformity and consistency in the Ayushbased responses to the pandemic across the country. It also helps State/UT
Governments to plan and incorporate these solutions into the COVID-19
management activities being deployed on the ground. Furthermore, these measures
and guidelines contribute to the mainstreaming of Ayush solutions for the
management of COVID-19, and will be immensely beneficial to the public since
these solutions are easily accessible and will help to alleviate the hardships brought
in by the pandemic.
These are aimed to increase awareness among the citizens regarding the effective
home care solutions and recommended Ayush practices, to help them to enhance
their immunity along with standard guideline for Ayurveda & Unani Practitioners
for management of prophylactic, Asymptomatic and Mild cases of COVID-19
during home isolation. Ministry of Ayush issued an advisory on 29.01.2020 on
how to protect oneself from COVID-19 and how to stay healthy. In this context,
Ministry of Ayush has also promoted use of ready-made formulation like ‘Ayush
Kwath’(Ayurveda) which is a simple admixture of four herbal ingredients which
are well known in India and outside India for their immunomodulatory and antiviral activities along with several other health benefits. Considering the seasonal
changes, patient’s constitution it has been advised that Vasa (Malabar nut),
Yashtimadhu (Liquorice root) and Guduchi (Giloy) may be added to the Kwatha as
per requirement.
Keeping note on the present public health challenges due to second wave of
COVID-19 pandemic, there is an urgent requirement to disseminate information
about the Guidelines for Ayurveda & Unani Practitioners for the management of
COVID-19 patients during home isolation. The effective evidence based Ayurveda
and Unani formulations/measures such as AYUSH-64, Ashwagandha tablets etc.
have been included for the management of Asymptomatic and Mild cases of
COVID-19 during home isolation.
These guidelines are provided as separate documents on the Ayush Ministry’s
website. Further, similar guidelines based the other Ayush systems are expected to
be released shortly.